Axillary Artery Access for Mechanical Circulatory Support Devices in Patients With Prohibitive Peripheral Arterial Disease Presenting With Cardiogenic Shock

Am J Cardiol. 2019 May 15;123(10):1715-1721. doi: 10.1016/j.amjcard.2019.02.033. Epub 2019 Feb 27.

Abstract

In patients with severe peripheral vascular disease, the common femoral artery may be so diseased as to not allow for deployment of mechanical circulatory support (MCS) such as in the setting of cardiogenic shock (CS). We sought to study the feasibility of axillary artery as alternative access for MCS in CS patients with severe occlusive peripheral artery disease (PAD). Records of all patients who presented with CS requiring MCS through axillary artery access from January 2016 to October 2017 were examined. Demographics, clinical, procedural, and outcomes data were collected on all patients. A total of 17 patients (mean age 68 ± 14years, 95% men) were identified. This was due to severe PAD in the iliac and/or common femoral arteries prohibiting large bore sheath access in allcases. Of the 17 patients, 9 required percutaneous coronary intervention. Time from axillary access to activation of Impella was 14.8 ± 4 minutes. Three patients required concomitant Impella RP for right ventricular support due to biventricular CS. Twelve patients died before Impella was explanted due to multiorgan failure, stroke, and infection. None of the patients who died had vascular complications related to axillary access. All 5 patients who survived to Impella explant were discharged from the hospital without major complication. Axillary artery is a safe and feasible alternative access for large bore devices in patients with prohibitive PAD. The meticulous technique described assures a very low rate of access related complications.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Angiography
  • Axillary Artery
  • Cardiac Catheterization / methods*
  • Female
  • Follow-Up Studies
  • Heart-Assist Devices*
  • Humans
  • Male
  • Middle Aged
  • Peripheral Arterial Disease / complications*
  • Peripheral Arterial Disease / diagnosis
  • Retrospective Studies
  • Shock, Cardiogenic / complications
  • Shock, Cardiogenic / mortality
  • Shock, Cardiogenic / therapy*
  • Survival Rate / trends
  • United States / epidemiology
  • Young Adult